143 related articles for article (PubMed ID: 29723371)
1. Effectiveness of the retreatment of patients with multibacillary leprosy and episodes of erythema nodosum leprosum and/or persistent neuritis: a single-center experience.
Lastória JC; Almeida TSC; Putinatti MSMA; Padovani CR
An Bras Dermatol; 2018 Mar; 93(2):181-184. PubMed ID: 29723371
[TBL] [Abstract][Full Text] [Related]
2. Bullous Erythema Nodosum Leprosum as the First Manifestation of Multibacillary Leprosy: A Rare Phenomenon.
Bakshi N; Rao S; Batra R
Am J Dermatopathol; 2017 Nov; 39(11):857-859. PubMed ID: 28763338
[TBL] [Abstract][Full Text] [Related]
3. Histoid leprosy complicated by erythema nodosum leprosum mimicking connective tissue disease.
Pal D
Trop Doct; 2023 Oct; 53(4):533-535. PubMed ID: 37401254
[TBL] [Abstract][Full Text] [Related]
4. A dissimulate presentation of histoid Hansen's disease in the form of erythema nodosum leprosum.
Pathania V; Oberoi B; Baveja S; Shelly D; Venugopal R; Shankar P
Int J Mycobacteriol; 2019; 8(2):208-210. PubMed ID: 31210170
[TBL] [Abstract][Full Text] [Related]
5. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition.
Costa PDSS; Fraga LR; Kowalski TW; Daxbacher ELR; Schuler-Faccini L; Vianna FSL
Acta Trop; 2018 Jul; 183():134-141. PubMed ID: 29474830
[TBL] [Abstract][Full Text] [Related]
6. Recognizing and managing the immunologic reactions in leprosy.
Kamath S; Vaccaro SA; Rea TH; Ochoa MT
J Am Acad Dermatol; 2014 Oct; 71(4):795-803. PubMed ID: 24767732
[TBL] [Abstract][Full Text] [Related]
7. Apremilast in multibacillary leprosy patients with chronic and recurrent erythema nodosum leprosum: a prospective single-centre pilot study.
Narang T; Ashraf R; Kaushik A; Dogra S
J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):e917-e919. PubMed ID: 34365679
[No Abstract] [Full Text] [Related]
8. Pentoxifylline in the treatment of erythema nodosum leprosum.
De Carsalade GY; Achirafi A; Flageul B
J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
[TBL] [Abstract][Full Text] [Related]
9. Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil.
Hungria EM; Oliveira RM; Penna GO; Aderaldo LC; Pontes MA; Cruz R; Gonçalves HS; Penna ML; Kerr LR; Stefani MM; Bührer-Sékula S
Infect Dis Poverty; 2016 Dec; 5(1):110. PubMed ID: 27919284
[TBL] [Abstract][Full Text] [Related]
10. Chronic recalcitrant erythema nodosum leprosum: therapeutic dilemma and role of mycobacterium indicus pranii vaccine.
Gupta SK; Kumari S
An Bras Dermatol; 2022; 97(1):49-53. PubMed ID: 34848113
[TBL] [Abstract][Full Text] [Related]
11. Lucio's phenomenon: A systematic literature review of definition, clinical features, histopathogenesis and management.
Frade MAC; Coltro PS; Filho FB; Horácio GS; Neto AA; da Silva VZ; Westin AT; Guimarães FR; Innocentini LMAR; Motta ACF; Farina JA
Indian J Dermatol Venereol Leprol; 2022; 88(4):464-477. PubMed ID: 34672479
[TBL] [Abstract][Full Text] [Related]
12. Reactive perforating leprosy: pustular erythema nodosum leprosum with epidermal perforation and liberation of Mycobacterium leprae.
Ghorpade A
Int J Dermatol; 2014 Feb; 53(2):221-3. PubMed ID: 24319988
[No Abstract] [Full Text] [Related]
13. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
14. Lichenoid Skin Nodules as Presenting Feature of Necrotic Erythema Nodosum Leprosum in Leprosy.
Kaushik A; Dogra S; Narang T
Am J Trop Med Hyg; 2020 Jul; 103(1):9. PubMed ID: 32653048
[No Abstract] [Full Text] [Related]
15. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Becx-Bleumink M; Berhe D
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
[TBL] [Abstract][Full Text] [Related]
16. Lepromatous leprosy in Saudi female from central region.
al-Majed S
J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1940331
[TBL] [Abstract][Full Text] [Related]
17. Utility and limitations of serodiagnostic tests in monitoring the response to treatment of leprosy patients.
Duthie MS; Roferos FO; Abellana JF; Taborada T; Sanchez R; Maghanoy A; Balagon MF
Diagn Microbiol Infect Dis; 2020 Apr; 96(4):114984. PubMed ID: 31954594
[TBL] [Abstract][Full Text] [Related]
18. Leprosy reactions in postelimination stage: the Bangladesh experience.
Mowla MR; Ara S; Mizanur Rahman AFM; Tripura SP; Paul S
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):705-711. PubMed ID: 27859670
[TBL] [Abstract][Full Text] [Related]
19. Asymmetrical ocular affliction in a case of recurrent erythema nodosum leprosum-an uncommon manifestation of leprosy in contemporary times.
Sachdeva S; Sardana K; Kumari R; Bhogar K; Khurana A; Malhotra P
Int J Dermatol; 2022 Nov; 61(11):e441-e443. PubMed ID: 35405022
[No Abstract] [Full Text] [Related]
20. Erythema nodosum leprosum and HIV infection: A therapeutic experience.
Sharma NL; Mahajan VK; Sharma VC; Sarin S; Sharma RC
Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):189-93. PubMed ID: 16830640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
